Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments

Project Information

MEDLEM

Grant agreement ID: 690876

DOI 10.3030/690876

Project closed

EC signature date 14 December 2015

Start date 1 January 2016

End date 31 December 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 333 000,00

EU contribution € 283 500,00

Coordinated by

UNIVERZITET U NOVOM SADU
Serbia

• Targeting leukaemia with personalised treatment
  EN